GlassScriptPhysician profile
John C Cedarholm
NPI 1356353379
$1,963.57
in general payments reported to CMS, 2019-2025
18 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $13.67 · 2021: $101 · 2022: $416 · 2023: $332 · 2024: $472 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049 · Education: $15.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.21 |
| Education | $15.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $468.96 | 2021-2024 | Xarelto |
| Amgen INC. | $204.31 | 2021-2025 | Repatha, Repatha |
| Inari Medical, INC. | $191.38 | 2019-2020 | |
| Abiomed | $190.07 | 2019-2025 | |
| Abbott Laboratories | $165.69 | 2021-2024 | Mitraclip |
| Boston Scientific Corporation | $146.13 | 2019-2024 | Watchman Flx |
| Pfizer INC. | $135.13 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $93.80 | 2023 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $78.77 | 2022-2023 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.35 | 2023-2025 | Lifevest |
| Livanova USA, INC. | $42.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.42 | 2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $41.35 | 2024 | |
| Edwards Lifesciences Corporation | $24.77 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cvrx, INC. | $21.33 | 2025 | Barostim Neo System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.45 | 2025 | |
| Philips North America LLC | $16.47 | 2022 | |
| Medicomp INC | $12.21 | 2024 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cedarholm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.